PK-guided personalized prophylaxis with Nuwiq (R) (human-cl rhFVIII) in adults with severe haemophilia A
dc.contributor.author | Lissitchkov, T | en_US |
dc.contributor.author | Rusen, L | en_US |
dc.contributor.author | Georgiev, P | en_US |
dc.contributor.author | Windyga, J | en_US |
dc.contributor.author | Klamroth, R | en_US |
dc.contributor.author | Gercheva, L | en_US |
dc.contributor.author | Nemes, L | en_US |
dc.contributor.author | Tiede, A | en_US |
dc.contributor.author | Bichler, J | en_US |
dc.contributor.author | Knaub, S | en_US |
dc.contributor.author | Belyanskaya, L | en_US |
dc.contributor.author | Walter, O | en_US |
dc.contributor.author | Pasi, KJ | en_US |
dc.date.accessioned | 2017-08-07T13:38:25Z | |
dc.date.available | 2017-03-16 | en_US |
dc.date.issued | 2017-09 | en_US |
dc.date.submitted | 2017-07-18T11:07:22.684Z | |
dc.identifier.issn | 1351-8216 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/25089 | |
dc.description.sponsorship | Octapharma AG (Lachen, Switzerland) | en_US |
dc.format.extent | 697 - 704 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | HAEMOPHILIA | en_US |
dc.rights | "This is the peer reviewed version of the following article: Lissitchkov, T., Rusen, L., Georgiev, P., Windyga, J., Klamroth, R., Gercheva, L., Nemes, L., Tiede, A., Bichler, J., Knaub, S., Belyanskaya, L., Walter, O. and Pasi, K. J. (2017), PK-guided personalized prophylaxis with Nuwiq® (human-cl rhFVIII) in adults with severe haemophilia A. Haemophilia. doi:10.1111/hae.13251, which has been published in final form at https://doi.org/10.1111/hae.13251. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving." | |
dc.subject | haemophilia A | en_US |
dc.subject | human-cl rhFVIII | en_US |
dc.subject | Nuwiq (R) | en_US |
dc.subject | personalized prophylaxis | en_US |
dc.subject | pharmacokinetics | en_US |
dc.subject | recombinant FVIII | en_US |
dc.title | PK-guided personalized prophylaxis with Nuwiq (R) (human-cl rhFVIII) in adults with severe haemophilia A | en_US |
dc.type | Article | |
dc.rights.holder | (c) The Author(s) 2017. | |
dc.identifier.doi | 10.1111/hae.13251 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411824500033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 5 | en_US |
pubs.notes | 12 months | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 23 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Immunobiology [1101]